Mobile UPI  |   About UPI  |   UPI en Español  |   UPI Arabic  |   UPIU  |   My Account
Search:
Go

Business News

Novartis to buy US firm Corthera for $120 mln

Dec. 23, 2009
Swiss pharmaceuticals maker Novartis AG said Wednesday it will buy U.S. biopharmaceutical company Corthera Inc. for $120 million, giving it the right to develop a new drug against heart failure. The acquisition of San Francisco-based Corthera is subject to...
Related Stories from UPI.com

Nestle buys Gerber for $5.5B

VEVEY, Switzerland, April 12 (UPI) -- Swiss package-food company Nestle SA said Thursday it would buy Gerber Products Co. from Swiss pharmaceuticals company Novartis AG for $5.5 billion.

ABN Amro paying $260M for Novartis unit

BASEL, Switzerland, Nov. 28 (UPI) -- Switzerland's Novartis AG said Monday it was selling its dietary food business to ABN Amro Capital France for about $260 million.

Novartis may build U.S. flu vaccine plant

NEW YORK, Nov. 3 (UPI) -- Novartis AG, the Swiss company that is buying U.S. flu vaccine maker Chiron Corp., says it may build a vaccine plant in the United States.

Novartis snaps up vaccine firm Chiron

WASHINGTON, Oct. 31 (UPI) -- Swiss drug maker Novartis has acquired California-based vaccine maker Chiron in a $5.1 billion cash deal.

OSI buying Eyetech for $935 million

MELVILLE, N.Y., Aug. 22 (UPI) -- OSI Pharmaceuticals Inc. said Monday it would buy Eyetech Pharmaceuticals Inc. for $935 million.
1 of 28
Lori Anne Madison, 6, competes in Scripps National Spelling Bee
View Caption
Lori Anne Madison, 6, of Woodbridge, Virginia, spells out the letters in her word as she competes during the opening round of the Scripps National Spelling Bee, May 30, 2012, in National Harbor, Maryland. Madison, the youngest known qualifier in the history of the contest, correctly spelled the word "dirigible*", a lighter-than-air aircraft, to advance. UPI/Mike Theiler